Lamotrigine Tablet
Product Images NDC 50090-2130

9 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50090-2130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2d955155 686d 40cd 898e Df7d760247a5 740 1

FDA Label Image

2d955155 686d 40cd 898e Df7d760247a5 789 2

2d955155 686d 40cd 898e Df7d760247a5 789 2
Lamotrigine tablets in four strengths: 25 mg white oval tablets with imprint 'U 111', 100 mg white triangular tablets with imprint 'U 112', 150 mg white triangular tablets with imprint 'U 113', and 200 mg light blue triangular tablets with imprint 'U 114'.*
FDA Label Image

2d955155 686d 40cd 898e Df7d760247a5 789 3

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01
Chemical structure of Lamotrigine, displaying a triazine ring substituted with amino groups and a dichlorophenyl group, consistent with the active ingredient Lamotrigine in oral tablet form by A-S Medication Solutions.*
FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02
A Kaplan-Meier survival curve chart comparing failure probability (%) over weeks for Lamotrigine versus placebo. The graph shows two lines representing failure rates, with the placebo line above Lamotrigine, indicating higher failure probability over time. The chart includes censored data points marked with crosses.*
FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03
A Kaplan-Meier survival curve chart displaying failure probability (%) over time in weeks. The graph compares two groups labeled as Placebo and Lamotrigine, with failure probability increasing over time in both groups but at different rates. The chart includes markers for censored data points.*
FDA Label Image

Label Image (Lbl500902129)

Label Image (Lbl500902129)
Lamotrigine 25 mg oral tablets packaging label by A-S Medication Solutions. The label shows the product name Lamotrigine, dosage strength of 25 mg, and storage instructions to store at 68 to 77 degrees Fahrenheit and keep in a dry place. The package contains 60 tablets.*
FDA Label Image

Label Image (Lbl500902130)

Label Image (Lbl500902130)
Lamotrigine 100 mg oral tablets label from A-S Medication Solutions. The label specifies the strength as 100 mg per scored tablet, the package contains 30 tablets, and storage instructions indicate keeping the product between 68 to 77 degrees Fahrenheit in a dry place. The label also includes the NDC number 50090-2130-0 and a lot number field.*
FDA Label Image

Label Image (Lbl500902131)

Label Image (Lbl500902131)
Label for Lamotrigine 150 mg oral tablets by A-S Medication Solutions. The label includes NDC 50090-2131-0 and Product No. 6490-0. Storage instructions specify keeping the product at 68 to 77 degrees Fahrenheit in a dry place. The package contains 60 tablets and is distributed by A-S Medication Solutions in Libertyville, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.